Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126455421 | 12645542 | 1 | I | 20160615 | 20160728 | 20160811 | 20160811 | EXP | TO20161559 | FR-VALIDUS PHARMACEUTICALS LLC-FR-2016VAL002407 | VALIDUS | 67.00 | YR | F | Y | 0.00000 | 20160811 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126455421 | 12645542 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, DAILY | 16273 | 40 | MG | TABLET | |||||||
| 126455421 | 12645542 | 2 | SS | CANDESARTAN CILEXETIL. | CANDESARTAN CILEXETIL | 1 | Oral | 4 MG, DAILY | 0 | 4 | MG | ||||||||
| 126455421 | 12645542 | 3 | C | LERCAN | LERCANIDIPINE | 1 | UNK | 0 | |||||||||||
| 126455421 | 12645542 | 4 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 126455421 | 12645542 | 5 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 126455421 | 12645542 | 6 | C | HYPERIUM | RILMENIDINE PHOSPHATE | 1 | UNK | 0 | |||||||||||
| 126455421 | 12645542 | 7 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 126455421 | 12645542 | 8 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 126455421 | 12645542 | 9 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | 0 | |||||||||||
| 126455421 | 12645542 | 10 | C | NOVORAPID | INSULIN ASPART | 1 | UNK | 0 | |||||||||||
| 126455421 | 12645542 | 11 | C | TARDYFERON B9 /06849301/ | 2 | UNK | 0 | ||||||||||||
| 126455421 | 12645542 | 12 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126455421 | 12645542 | 1 | Product used for unknown indication |
| 126455421 | 12645542 | 2 | Product used for unknown indication |
| 126455421 | 12645542 | 3 | Product used for unknown indication |
| 126455421 | 12645542 | 4 | Product used for unknown indication |
| 126455421 | 12645542 | 5 | Product used for unknown indication |
| 126455421 | 12645542 | 6 | Product used for unknown indication |
| 126455421 | 12645542 | 7 | Product used for unknown indication |
| 126455421 | 12645542 | 8 | Product used for unknown indication |
| 126455421 | 12645542 | 9 | Product used for unknown indication |
| 126455421 | 12645542 | 10 | Product used for unknown indication |
| 126455421 | 12645542 | 11 | Product used for unknown indication |
| 126455421 | 12645542 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126455421 | 12645542 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126455421 | 12645542 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |